THE ACCUMULATION OF ALVEOLAR SURFACTANT is regulated at the levels of synthesis, secretion, recycling, and degradation by diverse physiological and humoral stimuli (7) . The mechanisms regulating surfactant homeostasis are not completely understood, but it is generally believed that surfactant protein (SP) A, SP-B, SP-C, and SP-D play important roles (3, 17) . Contrary to expectations, the generation of mice with targeted deletions of the SP-A gene demonstrated that SP-A was not essential for either normal surfactant accumulation or function (13) . SP-D was not previously believed to have a significant role in either surfactant function or homeostasis. Therefore, the observation that targeted deletions of SP-D increased saturated phosphatidylcholine (Sat PC) in the alveolus and lung parenchyma was unexpected (2, 15) . Morphological consequences of SP-D deletion included the presence of abnormally large alveolar type II cell lamellar bodies, increased peribronchial lymphoid tissue, and enlargement of alveolar air spaces. Alveolar macrophages accumulated progressively, exceeding six times the normal value by 10 wk of age. Alveolar macrophages in SP-D-deficient [SP-D(Ϫ/Ϫ)] mice also became larger with advancing age, with increased phospholipid and neutral lipid content (2, 15) . Although the mechanism underlying the increased phospholipid content in SP-D(Ϫ/Ϫ) mice remains unclear, accumulation of alveolar and intracellular Sat PC occurs in the presence of only modest changes in the incorporation of [ 3 H]choline by lung tissue, indicating that alterations in both the synthesis and degradation of phospholipids might contribute to the abnormalities seen in SP-D(Ϫ/Ϫ) mice (2) .
Although SP-D is expressed abundantly in the respiratory epithelium, SP-D is also expressed in various tissues including the gastrointestinal tract, pancreas, and heart (6, 20) . It is therefore unclear whether the observed abnormalities in surfactant homeostasis of SP-D(Ϫ/Ϫ) mice are mediated by the direct effects of SP-D on lung metabolism or indirectly by influencing metabolism in other organs. In normal humans, the normal range of alveolar SP-D abundance varies from 0.7 to 49 ng/nM phospholipid (9) . Such differences have no known physiological significance. An apparent in-
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verse relationship between alveolar phospholipid and SP-D and SP-A after acute endotoxin exposure (19) is consistent with a potential physiological role for SP-D in decreasing alveolar surfactant abundance. However, a 50% reduction in the abundance of SP-D does not alter surfactant accumulation or macrophage morphology (15) .
In the present study, we sought to determine whether SP-D functioned locally within the lung to regulate surfactant pool size, alveolar macrophage abundance, and morphology and whether the increased expression of SP-D altered lung phospholipid and metabolism or regulated endogenous SP-D expression in the mouse. To increase SP-D concentration in the lung, a construct with the human SP-C promoter (14) and a rat SP-D (rSP-D) cDNA clone (23) 
METHODS

Vector Construction
The entire rSP-D coding sequence, including the polyadenylation signal, was excised with EcoR I from a previously reported cDNA clone (23) and cloned into a unique EcoR I site in an expression construct between the human SP-C promoter and SV40 polyadenylation sequence (27) . One correctly oriented clone was expanded and purified with a Qiagen Plasmid Purification Kit (Qiagen, Hilden, Germany). The construct was then linearized by double digestion with Not I and Nde I and separated from the plasmid sequences on an agarose gel with a DEAE cellulose membrane (NA45, Schleicher & Schuell, Keene, NH) as previously described (22) .
Transgenic Strains
Fertilized eggs were obtained from the mating of C57BL /6 ϫ C3H male and female mice. Pronuclei were injected with 4 µg/ml of linearized vector in a volume of 1-2 pl. Ova surviving the microinjection were inoculated into pseudopregnant B6/C3 hybrids obtained from Taconic (Germantown, NY) as previously described (8) . Mice were weaned at 3 wk of age, and DNA from tail clips was evaluated for the presence of the transgene by DNA blot analysis after digestion with EcoR I, with the entire rat SP-D cDNA as a probe and hybridization conditions as previously described (23) . The transgene was identified by the presence of a 1.3-kb hybridization band corresponding to rat cDNA. This probe also hybridized to a single 8-kb mouse SP-D restriction fragment. Relative abundance of mouse and rat DNAs was estimated by comparing the density of bands with a PhosphorImager (Molecular Dynamics, Sunnyvale, CA). To generate a stable genotype, mice transmitting the transgene in a manner consistent with single autosomal integration with a consistent copy number in successive generations were selected for further study. One strain with approximately two to three copies per genome was used for breeding experiments.
SP-D(Ϫ/Ϫ) mice were developed as previously described (15) 
SP Gene Expression
To assess mRNA accumulation for SP-A, SP-B, SP-C, and SP-D, RNA blots were probed with rat cDNA clones as previously described (12) . All blots were counterprobed with glyceraldehyde-3-phosphate dehydrogenase to verify equal RNA loading. Blots were scanned with a PhosphorImager from Molecular Dynamics. Signal intensity was compared between groups of four mice for each SP, and each experiment was repeated once for a total of eight mice per analysis. Western blots were performed as previously described (15) with an antibody raised in rabbits against purified rSP-D.
To assess endogenous mouse SP-D mRNA accumulation in SP-D(ϩ/ϩ) and rSP-D, SP-D(ϩ/ϩ) mice, we used a competitive PCR (1) . Primers specific for mouse or, alternatively, rat mRNA were designed as follows: mouse sense, 5Ј-CGTCTAGA-GGTTGCCTTCTCC-3Ј, and antisense, 3Ј-GGCTCAGACCTGTA-TGTTGCCA-5Ј; and rat sense, 5Ј-CTAGAGGCTGCCTTTTCT-CG-3Ј, and antisense, 3Ј-GGTATAGCTCAGACCTCTATG-5Ј. Although the sequences of the rat and mouse cDNAs are 92% identical, because of differences in the 3Ј-untranslated region, the above primer pairs are species specific. Competitors for PCRs were developed by conducting site-directed mutagenesis, deleting an internal Pvu II site in the mouse SP-D cDNA clone and a Pst I site in the rat cDNA clone. After experimental determination of an appropriate dilution of competitor to cDNA to achieve linearity, four 1:2 dilutions of mimic were combined with the master mix containing cDNA obtained from transgenic and normal mouse lung RNA by RT and amplified. Amplifications were done at an annealing temperature of 63°C with primer concentrations of 20 µM each and Life Technologies Platinum PCR SuperMix. On completion of 25 cycles, samples were precipitated with ethanol and subjected to digestion for 2 h with a 10-fold excess of Pvu II for mouse and Pst I for rat amplicons. The efficiency of RT was verified by comparing the intensity with that of amplified ␤-actin. A fraction of the sample was resolved on a Bio-Rad 10% TBE Ready Gel at 150 V for 1.5 h. The gel was stained with SYBR Green I (FMC BioProducts, Rockland, ME) and scanned on a Molecular Dynamics PhosphorImaging System. Relative abundance was calculated as previously described (1, 24) by comparison of the signal intensity ratios of unknown concentrations of mimic cDNA with the ratios obtained from a known input of cloned cDNA. The results are expressed as picograms of mRNA per microgram of total RNA input. To determine whether accumulation of SP-A varied depending on genotype, bronchoalveolar lavage (BAL) fluid, lung homogenate, and macrophage pellets were all subjected to SP-A ELISA as previously described (18) .
Surfactant Measurements
The 8-wk-old mice were given a weight-adjusted intraperitoneal injection of 0.03 µCi/g body weight of The lungs were processed as previously described (13, 15) . In brief, a 20-gauge catheter was tied into the trachea, and an extensive alveolar wash was recovered for each animal. The lungs were homogenized in saline. Sat PC was recovered by chromatography with neutral alumina columns from chloroform-methanol (2:1) extracts of alveolar washes and lung homogenates (13, 15) . Isolated Sat PC was divided for radioactivity measurement and phosphorous assay (10) . All values are given as means Ϯ SE.
Morphological Evaluation
Lungs from three mice of 10-12 wk of age of each genotype,
, and rSP-D, SP-D(Ϫ/Ϫ), were perfused free of blood with PBS, inflation fixed with Formalin infused at 20 cmH 2 O, embedded in paraffin, sectioned, and stained with hematoxylin and eosin. Representative sections that were not identified as to genotype were viewed by four individuals, three of whom had formal training as pathologists, and were scored as normal or abnormal. Abnormalities were described by each individual, and descriptions were compared between individuals. Immunostaining for SP-D was performed as previously described (6) . Macrophages from BAL fluid were counted with a hemacytometer. Morphological evaluations of BAL fluid macrophages at the light microscopy level were done with cytospin preparations and LeukoStat stain (Fisher Scientific) . Electron microscopy evaluation of BAL fluid macrophages was performed as previously described after fixation of a low-speed pellet of http://ajplung.physiology.org/ alveolar macrophages in 0.1 M sodium cacodylate, pH 7.2, and 2.5% glutaraldehyde (16) . Immunostaining was done as previously described (15, 23) .
Statistical Analysis
Differences between groups were evaluated with unpaired two-tailed t-tests, with P Ͻ 0.05 considered significant. For assessment of linkage, distribution of genotypes was evaluated with 2 analysis, with P Ͻ 0.05 considered significant.
RESULTS
Transgenic Lines
Fifteen independent rSP-D founders were identified by tail clip DNA blot analysis with rat cDNA as a probe. The copy number of the transgene in founders varied between 2 and 10 copies per genome as estimated by comparison of hybridization band intensity. Two males and two females with four to eight copies per genome http://ajplung.physiology.org/ were bred to a C57BL /6/C3H hybrid strain. Germ-line transmission was evident for all founders. Further breeding was into a C57/BL /6 background. Transgene transmission was assessed by PCR analysis with rSP-Dspecific cDNA primers, and copy number was assessed by DNA blot. Figure 1 is a representation of a DNA blot demonstrating integration of the transgene in the specific strain used for all systematic studies of SP-D transgene expression and subsequent breeding experiments. With an EcoR I digest, a full-length construct hybridization band is apparent at 1.3 kb and another more intense band is apparent at ϳ1.6 kb, indicating the integration of at least two and possibly three copies of the rat cDNA.
To confirm expression, RNA blot analysis was conducted with a mouse SP-D cDNA clone as a probe. The intensity of the RNA hybridization signal for the transgene appeared to be greater than that for the normal mouse and was identifiable as transgenic in origin because of a 150-bp size difference ( Fig. 2A) . With scanning densitometry of the blots probed with mouse cDNA, a band signal of approximately twice that of the normal mouse was obtained for the transgenic band, indicating at least a threefold increase in total SP-D mRNA in rSP-D, SP-D(ϩ/ϩ) mice. The hybridization intensity of rat mRNA is much greater when rat cDNA is used as a probe, indicating the difficulty of precise quantification of similar but not identical mRNA species with a slightly dissimilar probe. SP-D in the lung homogenate also appeared to be much greater than that in the normal mouse (Fig. 2B) . ELISA of lung homogenate and BAL fluid confirmed increased SP-D (Fig. 3) . There was no extrapulmonary SP-D transgene expression identified by RT-PCR analysis of stomach, intestine, pancreas, liver, and heart RNAs with ratspecific SP-D primers (data not shown). After four sequential outbreedings of one lineage, the transgene copy number stabilized, with approximately two to three copies per genome. This line was used for all further experiments. For experiments assessing phenotype, mice were heterozygous for the transgene locus. RNA blot and protein blot analyses from these lines are shown in Fig. 2, A and B . Immunohistochemical staining of acid alcohol-fixed sections demonstrated SP-D expression in the alveolar epithelium but more intense immunostaining in the small-airway epithelium. rSP-D mice demonstrated staining that was more intense than that in normal mice (Fig. 4) .
Analysis of rSP-D Mice
Lung structure. Three transgenic mice with SP-D expression of at least 20-fold of the normal value by comparison of Western blots from transgenic and normal littermates were studied at 10-12 wk of age. The lungs were removed from the thorax and inflation fixed to a pressure of 20 cmH 2 O with Formalin and examined after routine hematoxylin and eosin staining (Fig. 5 ). There were no consistent abnormalities identified between rSP-D, SP-D(ϩ/ϩ) and SP-D(ϩ/ϩ) mice when they were subjected to blinded analysis by four investigators. The number of alveolar macrophages recovered from BAL fluid was identical between normal mice and littermates expressing the transgene (1.45 Ϯ 1.4 ϫ 10 6 and 2.0 Ϯ 1.1 ϫ 10 6 cells in normal and transgenic mice, respectively; P ϭ 0.26; n ϭ 11 each), and there were no structural abnormalities of alveolar macrophages evaluated by both light (Fig. 5 ) and electron microscopy (data not shown). Differential counts were identical between the normal and overexpressing mice (data not shown).
SP gene expression. RNA blot analysis was conducted to estimate SP-A, SP-B, and SP-C mRNA abundance. There were no differences in mRNA for SP-A, SP-B, or SP-C between normal and rSP-D mice (Fig. 6) . To determine whether expression of the rSP-D transgene reduced the accumulation of steady-state mRNA for endogenous mouse SP-D, primer pairs were designed that were specific for rat or, alternatively, mouse SP-D cDNA. Specificity was confirmed with cDNA clones for both rSP-D and mouse SP-D and also by performing RT-PCR with RNA from mouse and rat lungs as templates. In mice with an ϳ20-fold increase in SP-D as assessed by Western blot and ELISA, no detectable decrease in endogenous mouse SP-D mRNA was observed 
Surfactant Sat PC Measurement
Twenty-four SP-D(ϩ/ϩ) and nineteen rSP-D, SP-D(ϩ/ϩ) mice were used for surfactant measurements.
There were no significant differences in body weight between the groups. Alveolar, lung, and total (alveolar plus lung tissue) pool sizes of Sat PC were not different between SP-D(ϩ/ϩ) and rSP-D, SP-D(ϩ/ϩ) mice (Fig.  7A) . Likewise, there were no differences in the incorporation of [ 3 H]choline into Sat PC between the normal and rSP-D transgenic mice 8 (Fig. 7B) and 24 (Fig. 7C) h after injection. 
Generation of Rescued rSP-D, SP-D(Ϫ/Ϫ) Mice
Expression of rSP-D in SP-D(Ϫ/Ϫ) Mice
Although rSP-D and mouse SP-D are nearly identical, it was possible that rSP-D might not be biologically active in mice. Furthermore, because the endogenous SP-D is expressed in various tissues, it was unclear whether pulmonary abnormalities in SP-D(Ϫ/Ϫ) mice were directly related to the local actions of SP-D in the lung. Therefore, we determined whether rSP-D would correct lung abnormalities in SP-D(Ϫ/Ϫ) mice. Lung histology, including macrophage morphology, normalized in the corrected rSP-D, SP-D(Ϫ/Ϫ) mice (Fig. 5, C, D, G, and  H) (Fig. 8B) . Therefore, the rat transgene was biologically active, correcting the abnormalities observed in the lungs of SP-D(Ϫ/Ϫ) mice.
DISCUSSION
The distal respiratory epithelial cell-specific expression of rSP-D in the mouse had no effect on lung Although SP-D mRNA has been detected in various tissues including the lung, heart, stomach, and kidney (20) , the present findings demonstrate that cellselective expression of recombinant SP-D restored the abnormalities in histology and lung surfactant concentrations seen in the SP-D(Ϫ/Ϫ) mice. In the normal lung, SP-D mRNA and protein are detected primarily in respiratory epithelial cells, including nonciliated respiratory epithelial cells or Clara cells, and alveolar type II cells in rat (9, 26) , human (4), and mouse (28) lungs. In the present study, the 3.7-kb human SP-C promoter was used to express the rat SP-D transgene. As previously described (14) , gene expression with the construct was confined to the lung, likely representing expression in both peripheral bronchiolar and alveolar type II epithelial cells as observed repeatedly with this SP-C gene promoter. Marked increases in SP-D abundance were demonstrated with antibodies that recognize both rSP-D and mouse SP-D but with a relatively higher affinity for rSP-D. The extent to which SP-D is elevated is difficult to quantify precisely, but when this antibody was used to probe equal loads of recombinant mouse SP-D or, alternatively, rSP-D on an immunoblot, Surfactant phospholipid synthesis, as assessed by metabolic labeling studies, is increased in the lungs of SP-D(Ϫ/Ϫ) mice (15) . In the present work, the rate of In summary, the present findings demonstrate that the local expression of SP-D corrects surfactant lipid content and reduces choline incorporation into Sat PC within the lung, supporting the hypothesis that SP-D regulates the metabolic functions of type II epithelial cells. It remains unclear whether SP-D also has a direct effect on macrophage function. SP-D appears to play a novel role in the regulation of lipid homeostasis, distinct from that seen in other forms of alveolar proteinosis in which both lipids and SPs accumulate, the latter effects being mediated primarily by abnormalities in alveolar macrophage-dependent clearance. The present findings support the hypothesis that SP-D plays a primary role in the regulation of surfactant metabolism by type II epithelial cells in the lung.
